RxDoctor Payments Data

Natalie Ellison

Family · Clanton, ALNPI 1881211043

Payments from drug & device makers

$1,798in general payments, 2019–2025

Across 108 payments — averaging $16.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$465
  • Novo Nordisk$263
  • Abbott$204
  • GSK$127
  • Boehringer Ingelheim$119
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$114
  • plus $506 from 12 others

What the payments were for

  • Food & beverage$1,798100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,798 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Medicare billing

Part B allowed, 2024
$20,467
Medicare patients
97
Services billed
761

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide85$89,096
MounjaroTirzepatide58$66,919
FarxigaDapagliflozin Propanediol51$51,194
JardianceEmpagliflozin27$36,099
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$33,100
RybelsusSemaglutide14$14,825
TradjentaLinagliptin14$12,180
Repatha SureclickEvolocumab13$8,739
Atorvastatin Calcium219$2,895
Albuterol Sulfate HfaAlbuterol Sulfate100$1,946
Levothyroxine Sodium146$1,739
Trazodone Hcl67$1,634
ValacyclovirValacyclovir Hcl17$1,592
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,525
Omeprazole77$1,492

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$263$103,92199 claims
Lilly USA, LLCMounjaro$81$66,91958 claims
AstraZenecaFarxiga$113$51,19451 claims
Boehringer IngelheimJardiance, Tradjenta$119$48,28041 claims
GSKTrelegy Ellipta$127$33,10048 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.

Other family in Clanton

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →